Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

International Paper's acquisition of DS Smith strengthens its global footprint, despite a 2.3% Q4 revenue decline, leading me ...

According to Benzinga Pro, Graphic Packaging Holding's peer group average for short interest as a percentage of float is 4.69 ...

Rosenblatt Securities analyst Barton Crockett maintained a Hold rating on Roku (ROKU – Research Report) today and set a price target of ...